Nautilus Biotechnology, Inc.
NAUT
$0.04
Change (1 day)
$3.46
Year High
$2.19
Year Low
Categories
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.
Revenue of Nautilus Biotechnology, Inc. (NAUT)
Revenue in 2023 (TTM): $
According to Nautilus Biotechnology, Inc.'s latest financial reports the company's current revenue (TTM) is $. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history of Nautilus Biotechnology, Inc.
Annual Revenue
| Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
|---|---|---|---|---|---|
| 2023 | $ | $-5,705,000 | $-74,303,000 | $-63,675,000 | $-63,675,000 |
| 2022 | $ | $-3,416,000 | $-54,508,000 | $-57,924,000 | $-63,740,000 |
| 2021 | $ | $-2,842,000 | $-47,473,000 | $-50,315,000 | $-50,315,000 |
| 2020 | $ | $-2,346,000 | $-13,273,000 | $-15,619,000 | $-15,619,000 |
| 2019 | $ | $ | $-9,562,000 | $-9,618 | $-9,618 |
| 2018 | $ | $ | $626.6 M | $626.6 M | $626.6 M |